Search Results - Jochen Utikal

Refine Results
  1. 1

    Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance by Lionel Larribère, Lionel Larribère, Jochen Utikal, Jochen Utikal

    Published in Frontiers in Molecular Neuroscience (2019-05-01)
    Get full text
    Article


  2. 2

    Tackling malignant melanoma epigenetically: histone lysine methylation by Elias Orouji, Jochen Utikal

    Published in Clinical Epigenetics (2018-11-01)
    Get full text
    Article


  3. 3

    Effective treatment of refractory, locally metastatic squamous cell carcinoma of the leg with isolated limb perfusion: a case report with unexpected long progression-free interval by Danai-Dionysia Kanatoula, Danai-Dionysia Kanatoula, Danai-Dionysia Kanatoula, Sebastian A. Wohlfeil, Sebastian A. Wohlfeil, Sebastian A. Wohlfeil, Jens Jakob, Peter Hohenberger, Jochen Utikal, Jochen Utikal, Jochen Utikal

    Published in Frontiers in Oncology (2025-03-01)
    Get full text
    Article


  4. 4

    The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression by Viktor Umansky, Carolin Blattner, Christoffer Gebhardt, Jochen Utikal

    Published in Vaccines (2016-11-01)
    Get full text
    Article


  5. 5

    Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients by Vera Petrova, Vera Petrova, Vera Petrova, Vera Petrova, Christopher Groth, Christopher Groth, Christopher Groth, Christopher Groth, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Sonja C. S. Simon, Svetlana Hetjens, Verena Müller, Jochen Utikal, Jochen Utikal, Jochen Utikal, Jochen Utikal, Viktor Umansky, Viktor Umansky, Viktor Umansky, Viktor Umansky

    Published in Frontiers in Immunology (2023-02-01)
    Get full text
    Article


  6. 6

    Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target by Feyza Gul Ozbay Kurt, Samantha Lasser, Ihor Arkhypov, Jochen Utikal, Viktor Umansky

    Published in The Journal of Clinical Investigation (2023-07-01)
    Get full text
    Article


  7. 7

    Corticotropin-Releasing Hormone in Melanoma and Nonmelanoma Skin Cancer by Marcel Mueller, Susanne Melchers, Iris Mueller, Jochen Utikal, Julia Krug, Astrid Schmieder

    Published in Journal of Skin Cancer (2025-01-01)
    Get full text
    Article


  8. 8

    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma by Johanna Matull, Johanna Matull, Jan-Malte Placke, Georg Lodde, Anne Zaremba, Jochen Utikal, Jochen Utikal, Jochen Utikal, Patrick Terheyden, Claudia Pföhler, Rudolf Herbst, Alexander Kreuter, Julia Welzel, Julia Kretz, Inga Möller, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Lisa Zimmer, Eva Hadaschik, Selma Ugurel, Dirk Schadendorf, Dirk Schadendorf, Dirk Schadendorf, Carl Maximilian Thielmann, Klaus Georg Griewank

    Published in Frontiers in Immunology (2024-06-01)
    Get full text
    Article


  9. 9

    Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs by Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Utikal, Viktor Umansky

    Published in OncoImmunology (2023-12-01)
    Get full text
    Article


  10. 10

    Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma by Aniello Federico, Tamara Steinfass, Lionel Larribère, Daniel Novak, Francisco Morís, Luz-Elena Núñez, Viktor Umansky, Jochen Utikal

    Published in Molecular Therapy: Oncolytics (2020-09-01)
    Get full text
    Article


  11. 11

    The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy by Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal

    Published in Molecular Oncology (2026-05-01)
    Get full text
    Article


  12. 12

    Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy by Raphael Reinhard, MD, Christoffer Gebhardt, MD, Nolwenn Maurier, MD, Lionel Larribère, PhD, Azadeh Orouji, MD, Jochen Utikal, MD

    Published in JAAD Case Reports (2018-03-01)
    Get full text
    Article


  13. 13

    NF1-RAC1 axis regulates migration of the melanocytic lineage by Lionel Larribère, Yohanes Cakrapradipta Wibowo, Nitin Patil, Mohammed Abba, Isabel Tundidor, Rubén Gerardo Aguiñón Olivares, Heike Allgayer, Jochen Utikal

    Published in Translational Oncology (2020-12-01)
    Get full text
    Article


  14. 14

    An RNAi Screen Reveals an Essential Role for HIPK4 in Human Skin Epithelial Differentiation from iPSCs by Lionel Larribère, Marta Galach, Daniel Novak, Karla Arévalo, Hans Christian Volz, Hans-Jürgen Stark, Petra Boukamp, Michael Boutros, Jochen Utikal

    Published in Stem Cell Reports (2017-10-01)
    Get full text
    Article


  15. 15

    Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status by Jan-Malte Placke, Jan-Malte Placke, Luisa Sophie Rajcsanyi, Luisa Sophie Rajcsanyi, Luisa Sophie Rajcsanyi, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Jochen Utikal, Jochen Utikal, Claudia Pföhler, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Michael Weichenthal, Friedegund Meier, Carola Berking, Ulrike Leiter, Johanna Seier, Frederik Krefting, Alpaslan Tasdogan, Alpaslan Tasdogan, Georg C. Lodde, Elisabeth Livingstone, Lisa Zimmer, Alexander Roesch, Alexander Roesch, Klaus Griewank, Dirk Schadendorf, Dirk Schadendorf, Selma Ugurel, Selma Ugurel

    Published in Frontiers in Immunology (2025-02-01)
    Get full text
    Article


  16. 16

    Impact of preconditioning with retinoic acid during early development on morphological and functional characteristics of human induced pluripotent stem cell-derived neurons by Sandra Horschitz, Friederike Matthäus, Anja Groß, Jan Rosner, Marta Galach, Wolfgang Greffrath, Rolf-Detlef Treede, Jochen Utikal, Patrick Schloss, Andreas Meyer-Lindenberg

    Published in Stem Cell Research (2015-07-01)
    Get full text
    Article


  17. 17

    Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg by Andrea Forschner, Katharina C. Kähler, Martin Gschnell, Ewan A. Langan, Ewan A. Langan, Carsten Weishaupt, Frank Meiss, Kai-Martin Thoms, Renate U. Wahl, Daniela Göppner, Marlene Garzarolli, Michael Sachse, Max Schlaak, Markus Reitmajer, Ivonne Kellner, Anja Gesierich, Peter Mohr, Friedegund Meier, Imke von Wasielewski, Rudolf Herbst, Jochen Utikal, Jochen Utikal, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Patrick Terheyden, Martin Kaatz, Sebastian Haferkamp, Ulrike Leiter, Selma Ugurel, Michael Weichenthal, Carola Berking, Ralf Gutzmer, Dirk Schadendorf, Lena Nanz, Carmen Loquai

    Published in Frontiers in Immunology (2025-02-01)
    Get full text
    Article


  18. 18

    391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab... by Evelyna Derhovanessian, Nicolas Acquavella, Christophe Massard, Carmen Loquai, Jochen Utikal, Jean-Francois Baurain, Oliver Bechter, Marie-Laure Ozoux, Rahul Marpadga, Esteban-Rodrigo Imedio

    Published in Journal for ImmunoTherapy of Cancer (2020-11-01)
    Article


  19. 19

    Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response by Mathias Bernhardt, Daniel Novak, Yassen Assenov, Elias Orouji, Nathalie Knappe, Kasia Weina, Maike Reith, Lionel Larribere, Christoffer Gebhardt, Christoph Plass, Viktor Umansky, Jochen Utikal

    Published in Stem Cell Reports (2017-05-01)
    Get full text
    Article


  20. 20

    Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models by Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, Daniel Baumann, Gal Cafri, Esther Tzehoval, Stefan B. Eichmüller, Rienk Offringa, Jochen Utikal, Lea Eisenbach, Viktor Umansky

    Published in OncoImmunology (2018-07-01)
    Get full text
    Article


Search Tools: